News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Jovan-Embiricos Morana
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/12/2023 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 35,000 shares
@ $0 |
|
08/04/2022 |
4
| F2 Vision SCS (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns:
| Sold 4,792 shares
@ $14.0973, valued at
$67.6k
Sold 19,129 shares
@ $14.2367, valued at
$272.3k
Sold 25,989 shares
@ $14.3056, valued at
$371.8k
|
|
08/01/2022 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 684,622 shares
@ $4.61, valued at
$3.2M
Granted 325,379 shares
@ $4.61, valued at
$1.5M
Granted 1,626,898 shares
@ $4.61, valued at
$7.5M
Granted 1,393,874 shares
@ $4.61, valued at
$6.4M
Granted 867,678 shares
@ $4.61, valued at
$4M
Granted 3,253,796 shares
@ $4.61, valued at
$15M
|
|
06/28/2022 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns:
| Paid exercise price by delivering 45,078 shares
@ $13.39, valued at
$603.6k
Exercised 104,845 options to buy
@ $4.3, valued at
$450.8k
Exercised 35,529 options to buy
@ $4.3, valued at
$152.8k
|
|
06/23/2022 |
4
| F2 Bioscience I 2017 Ltd (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns:
| Sold 22,319 shares
@ $12.7662, valued at
$284.9k
Sold 49,953 shares
@ $12.7035, valued at
$634.6k
Sold 29,631 shares
@ $13.0036, valued at
$385.3k
|
|
05/19/2022 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 27,500 options to buy
@ $4.6, valued at
$126.5k
|
|
05/16/2022 |
4
| F2 Vision SCS (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns:
| Sold 264,072 shares
@ $9.2497, valued at
$2.4M
Sold 85,319 shares
@ $9.9631, valued at
$850k
Sold 34,189 shares
@ $10.481, valued at
$358.3k
Sold 35,158 shares
@ $11.2301, valued at
$394.8k
|
|
03/25/2022 |
4
| Jovan-Embiricos Morana (Director) has filed a Form 4 on Cullinan Oncology, Inc.
Txns:
| Granted 7,800 options to buy
@ $28.8, valued at
$224.6k
|
|
01/13/2022 |
4
| F2 Vision SCS (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns:
| Disposed of 1,187,734 shares
@ $0 |
|
11/15/2021 |
4
| Jovan-Embiricos Morana (Director) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 680 shares
@ $24.765, valued at
$16.8k
Sold 120 shares
@ $24.765, valued at
$3k
|
|
11/09/2021 |
4
| Jovan-Embiricos Morana (Director) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 7,124 shares
@ $24.8047, valued at
$176.7k
Sold 1,257 shares
@ $24.8047, valued at
$31.2k
Sold 3,243 shares
@ $24.7882, valued at
$80.4k
Sold 572 shares
@ $24.7882, valued at
$14.2k
|
|
10/29/2021 |
4
| Jovan-Embiricos Morana (Director) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 1,870 shares
@ $24.7775, valued at
$46.3k
Sold 330 shares
@ $24.7775, valued at
$8.2k
|
|
10/25/2021 |
4
| Jovan-Embiricos Morana (Director) has filed a Form 4 on Allovir, Inc.
Txns:
| Sold 85 shares
@ $24.75, valued at
$2.1k
Sold 15 shares
@ $24.75, valued at
$371.3 Sold 4,864 shares
@ $24.7697, valued at
$120.5k
Sold 859 shares
@ $24.7697, valued at
$21.3k
Sold 6,604 shares
@ $24.8183, valued at
$163.9k
Sold 1,165 shares
@ $24.8183, valued at
$28.9k
|
|
05/27/2021 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 22,500 options to buy
@ $21.51, valued at
$484k
|
|
01/14/2021 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Cullinan Management, Inc.
Txns:
| Converted 1,136,525 shares
@ $0 Converted 2,912,345 shares
@ $0 Converted 639,295 shares
@ $0 Converted 455,338 shares
@ $0 Converted 182,135 shares
@ $0 Converted 71,599 shares
@ $0 Converted 143,198 shares
@ $0 Converted 71,599 shares
@ $0 Converted 214,798 shares
@ $0 Bought 95,238 shares
@ $21, valued at
$2M
Bought 104,762 shares
@ $21, valued at
$2.2M
|
|
08/06/2020 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Converted 13,420,970 shares
@ $0 Converted 247,011 shares
@ $0 Converted 1,399,732 shares
@ $0 Converted 411,685 shares
@ $0 Bought 100,000 shares
@ $17, valued at
$1.7M
Bought 2,800,000 shares
@ $17, valued at
$47.6M
Converted 20,000,000 convertible preferred
@ $0 Converted 368,098 convertible preferred
@ $0 Converted 2,085,889 convertible preferred
@ $0 Converted 613,496 convertible preferred
@ $0 |
|
07/31/2020 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns:
| Granted 22,500 options to buy
@ $17, valued at
$382.5k
|
|
12/20/2019 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Sold 458 shares
@ $17.006, valued at
$7.8k
Sold 2,433 shares
@ $17.006, valued at
$41.4k
Sold 6,642 shares
@ $16.4714, valued at
$109.4k
Sold 35,323 shares
@ $16.4714, valued at
$581.8k
Disposed of 586,153 shares
@ $0 Disposed of 13,847 shares
@ $0 |
|
12/11/2019 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Sold 20,886 shares
@ $17.6511, valued at
$368.7k
Sold 24,966 shares
@ $17.6511, valued at
$440.7k
Sold 19,070 shares
@ $17.6511, valued at
$336.6k
Sold 75,067 shares
@ $17.6511, valued at
$1.3M
Sold 8,479 shares
@ $17.6232, valued at
$149.4k
Sold 10,135 shares
@ $17.6232, valued at
$178.6k
Sold 7,741 shares
@ $17.6232, valued at
$136.4k
Sold 30,475 shares
@ $17.6232, valued at
$537.1k
Sold 1,155 shares
@ $17.6525, valued at
$20.4k
Sold 1,381 shares
@ $17.6525, valued at
$24.4k
Sold 1,054 shares
@ $17.6525, valued at
$18.6k
|
|
10/24/2019 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Sold 580 shares
@ $15.1571, valued at
$8.8k
Sold 693 shares
@ $15.1571, valued at
$10.5k
Sold 530 shares
@ $15.1571, valued at
$8k
Sold 2,085 shares
@ $15.1571, valued at
$31.6k
|
|
09/24/2019 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Sold 54,907 shares
@ $17.9354, valued at
$984.8k
Sold 24,446 shares
@ $17.9354, valued at
$438.4k
Sold 12,537 shares
@ $17.9354, valued at
$224.9k
Sold 65,633 shares
@ $17.9354, valued at
$1.2M
Sold 50,134 shares
@ $17.9354, valued at
$899.2k
Sold 197,343 shares
@ $17.9354, valued at
$3.5M
Sold 1,535 shares
@ $17.3114, valued at
$26.6k
Sold 683 shares
@ $17.3114, valued at
$11.8k
Sold 351 shares
@ $17.3114, valued at
$6.1k
Sold 1,835 shares
@ $17.3114, valued at
$31.8k
Sold 1,401 shares
@ $17.3114, valued at
$24.3k
|
|
09/05/2019 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Sold 500 shares
@ $17, valued at
$8.5k
Sold 100 shares
@ $17.03, valued at
$1.7k
Sold 3 shares
@ $17, valued at
$51 Sold 29,128 shares
@ $17.0104, valued at
$495.5k
Sold 1,200 shares
@ $17.0113, valued at
$20.4k
Sold 6,700 shares
@ $17.0061, valued at
$113.9k
Sold 3,700 shares
@ $17.0068, valued at
$62.9k
Sold 10,559 shares
@ $17.0142, valued at
$179.7k
Sold 12,214 shares
@ $17.5548, valued at
$214.4k
|
|
02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/15/2015 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns:
| Disposed of 251,680 shares
@ $0 Disposed of 335,820 shares
@ $0 |
|
01/12/2015 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns:
| Disposed of 389,331 shares
@ $0 Disposed of 89,261 warrants
@ $2.694, valued at
$240.5k
|
|
12/19/2014 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns:
| Granted 30,000 options to buy
@ $30.97, valued at
$929.1k
|
|
06/13/2014 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns:
| Converted 1,794,983 shares
@ $0 Converted 871,851 shares
@ $0 Bought 587,500 shares
@ $8, valued at
$4.7M
Converted 227,938 convertible preferred
@ $0 Converted 110,713 convertible preferred
@ $0 |
|
06/10/2014 |
4
| Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns:
| Converted 1,557,328 shares
@ $0 Converted 325,627 convertible preferred
@ $0 |
|
02/19/2014 |
4
| Jovan-Embiricos Morana (Director) has filed a Form 4 on Radius Health, Inc.
Txns:
| Granted 227,938 convertible preferred
@ $61.42, valued at
$14M
Granted 110,713 convertible preferred
@ $61.42, valued at
$6.8M
Granted 569,845 warrants
@ $6.142, valued at
$3.5M
Granted 276,783 warrants
@ $6.142, valued at
$1.7M
|
|
|
|